India’s apex clinical trial regulation body will meet urgently to reconsider Serum Institute of India’s proposal after it revised its plan for starting Oxford vaccine's human trials in India.
While US infectious diseases expert Anthony Fauci said long-term effects of exposure to Covid are yet unknown, others said human challenge trials could quicken vaccine search.
OSD in the health ministry Rajesh Bhushan says India is in talks with various stakeholders on vaccines, but has not yet signed any agreement with a vaccine manufacturer.
Even if an effective Covid vaccine is licensed, the manufacturing of doses for administration to world’s population will need collaboration among manufactures.
US infectious disease expert Anthony Fauci said the trial, to be tested at 89 sites, is designed to show the vaccine is at least 60% effective in preventing Covid.
The Serum Institute of India will start manufacturing the vaccine even before the final nod so it is ready with sizeable volumes once the vaccine gets all permissions.
Freight companies face problems ranging from shrinking capacity on container ships and cargo aircraft to a lack of visibility on when a vaccine will arrive.
In a recent survey of law school admissions officers, 94% said the current political climate in the US played at least a moderate role in the increase.
New CPI series will take 2024 as base year, will provide more accurate measure of inflation, spending on digital services. Expected to enhance representation and reliability, says Saurabh Garg.
The agreement, signed after meeting between Rajnath and US Secretary of War Pete Hegseth on sidelines of ADMM-Plus in Kuala Lumpur, aims to deepen bilateral ties in the critical sector.
On 21 Oct, a buzz went up that the govt had released full list of gallantry award recipients along with Op Sindoor citations. I put an AI caddy on the job. It took me into a never-ending rabbit hole.
COMMENTS